ATLANTA, GA -- (Marketwired) -- 02/02/17 -- . (OTCQB: GOVX), a biotechnology company developing human vaccines using its novel platform technology, today noted that its Chief Scientific Officer, Farshad Guirakhoo, PhD, has been featured in the article "Update on Zika Research" appearing i ...
↧